Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults
Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in...
Saved in:
Published in | Endocrinology and metabolism (Seoul) Vol. 37; no. 2; pp. 333 - 343 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Endocrine Society
01.04.2022
대한내분비학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-596X 2093-5978 2093-5978 |
DOI | 10.3803/EnM.2021.1202 |
Cover
Abstract | Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. |
---|---|
AbstractList | Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults. This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low." The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively. We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.BACKGROUNDHomocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low."METHODSThis was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low."The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.RESULTSThe prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.CONCLUSIONWe demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults. Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseaseswho underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemiawas defined as >15 µmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those withmildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model,hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval[CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformedhomocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively. Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. KCI Citation Count: 0 |
Author | Seo, Jin-Woo Park, Chul-Hyun Choi, Jae-Hyeong Lee, Yong-Taek Yoon, Kyung Jae Lee, Mi-Yeon |
AuthorAffiliation | 3 Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea 2 Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea 1 Department of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 3 Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea – name: 1 Department of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea – name: 2 Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Jae-Hyeong orcidid: 0000-0002-4945-4877 surname: Choi fullname: Choi, Jae-Hyeong – sequence: 2 givenname: Jin-Woo orcidid: 0000-0003-0004-1913 surname: Seo fullname: Seo, Jin-Woo – sequence: 3 givenname: Mi-Yeon surname: Lee fullname: Lee, Mi-Yeon – sequence: 4 givenname: Yong-Taek surname: Lee fullname: Lee, Yong-Taek – sequence: 5 givenname: Kyung Jae orcidid: 0000-0002-2765-4309 surname: Yoon fullname: Yoon, Kyung Jae – sequence: 6 givenname: Chul-Hyun orcidid: 0000-0002-9897-6612 surname: Park fullname: Park, Chul-Hyun |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35144330$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002834865$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNptks9vFCEUxyemxtbao1fD0ZjsCsMwwMVk06x2k91otCbeCANvKl0G2oFts_-97G7bWCMH3gt83-fx4_u6OgoxQFW9JXhKBaYf52E1rXFNpqTML6qTGks6YZKLo6e8_XVcnaV0jcsQoiE1eVUdU0aahlJ8UtlZStE4nV0MqIN8DxDQ3MOdzmDRN6_ToNFFHKLZpgwuANLBomW8Rz_W4CFrj1abZDyglU4JuYBmaTvc5DgUpEEzu_E5vale9tonOHuIp9XPz_PL84vJ8uuXxflsOTGNEHkC0GjMW26lxbhvhWmkMZIAIZ3u6kZyy0HytpdMMiF2GWWdkQY6jBkTnJ5WHw7cMPZqbZyK2u3jVVTrUc2-Xy4UwbhuOW-LeHEQ26iv1c3oBj1u9xX7hTheKT2WO3hQjRaaYdEawvvG1q00fUMo76zhtAcDhfXpwLrZdANYAyGP2j-DPt8J7nc51J2SWBBKSAG8fwCM8XYDKavBJQPe6wBxk1Td1oJiwhgr0nd_93pq8vinRUAPAjPGlEbolXF5_8GltfPlBdTOPKqYR-3Mo3bmKVWTf6oewf_X_wGoWMWP |
CitedBy_id | crossref_primary_10_2147_IJGM_S416230 crossref_primary_10_3389_fgene_2022_1051047 crossref_primary_10_1186_s12877_022_03632_0 crossref_primary_10_4103_bbrj_bbrj_234_24 crossref_primary_10_3390_nu16193322 crossref_primary_10_1007_s11010_023_04761_9 crossref_primary_10_1038_s41598_024_76693_3 crossref_primary_10_3389_fnut_2024_1369331 crossref_primary_10_1038_s41598_022_16401_1 |
Cites_doi | 10.1152/ajpendo.00301.2007 10.1016/j.exger.2020.110832 10.1515/cclm.2004.072 10.1152/ajpheart.00099.2015 10.1111/ggi.12723 10.1139/cjpp-2020-0093 10.1007/s40520-016-0717-0 10.1016/j.gerinurse.2014.03.001 10.1038/ejcn.2011.151 10.1146/annurev.nu.12.070192.001431 10.1016/j.amjcard.2016.01.033 10.1097/bor.0b013e328358d59b 10.3945/ajcn.2009.28256 10.1590/s0100-879x2009007500021 10.1038/ejcn.2013.97 10.1016/j.arr.2018.10.010 10.1016/j.ejim.2014.04.011 10.1053/meta.2001.23286 10.1002/jcb.25841 10.1007/s12272-018-1016-4 10.1093/qjmed/hcn112 10.1155/2019/9276097 10.3390/ijms140715074 10.1038/s41598-020-76185-0 10.1007/s11864-019-0691-9 10.1007/s12603-013-0336-9 10.1016/s0140-6736(19)31138-9 10.1046/j.1532-5415.2002.50216.x 10.1016/j.bbadis.2015.01.008 10.12965/jer.1836268.134 10.1093/ageing/afz046 10.1016/j.jstrokecerebrovasdis.2020.105259 10.1001/jamasurg.2020.2497 10.1093/ajcn/88.3.738 10.1016/j.tipsro.2020.10.001 10.1056/nejm199801013380101 10.1016/j.jamda.2014.11.011 10.1093/gerona/glx161 10.3389/fnut.2019.00049 10.1038/s12276-019-0216-4 10.1016/j.jamda.2014.02.005 10.1136/bmjopen-2017-021232 10.1787/5js1qwkz2p9s-en 10.1111/resp.13877 10.1007/s13539-012-0078-2 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Korean Endocrine Society 2022 |
Copyright_xml | – notice: Copyright © 2022 Korean Endocrine Society 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA ACYCR |
DOI | 10.3803/EnM.2021.1202 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-5978 |
EndPage | 343 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10026776 oai_doaj_org_article_4a8a5086c17f4d269cf4137bdc73fece PMC9081311 35144330 10_3803_EnM_2021_1202 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: 2020R1F1A107615712 – fundername: Ministry of Science and ICT |
GroupedDBID | 5-W 53G 5VS 8JR 8XY AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EF. GROUPED_DOAJ HYE HZB KQ8 M48 OK1 PGMZT RPM ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c488t-ee4a0767d9d00f68c49cc91e11bab2497d7e976f959588976f35bc9ceb0055873 |
IEDL.DBID | M48 |
ISSN | 2093-596X 2093-5978 |
IngestDate | Sun Mar 09 07:51:27 EDT 2025 Wed Aug 27 01:27:25 EDT 2025 Thu Aug 21 17:03:19 EDT 2025 Thu Jul 10 19:19:55 EDT 2025 Tue Apr 29 09:42:36 EDT 2025 Tue Jul 01 01:37:49 EDT 2025 Thu Apr 24 22:53:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Muscle, skeletal Homocysteine Sarcopenia |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c488t-ee4a0767d9d00f68c49cc91e11bab2497d7e976f959588976f35bc9ceb0055873 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0002-2765-4309 0000-0002-9897-6612 0000-0002-4945-4877 0000-0003-0004-1913 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2021.1202 |
PMID | 35144330 |
PQID | 2628301555 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10026776 doaj_primary_oai_doaj_org_article_4a8a5086c17f4d269cf4137bdc73fece pubmedcentral_primary_oai_pubmedcentral_nih_gov_9081311 proquest_miscellaneous_2628301555 pubmed_primary_35144330 crossref_citationtrail_10_3803_EnM_2021_1202 crossref_primary_10_3803_EnM_2021_1202 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Endocrinology and metabolism (Seoul) |
PublicationTitleAlternate | Endocrinol Metab (Seoul) |
PublicationYear | 2022 |
Publisher | Korean Endocrine Society 대한내분비학회 |
Publisher_xml | – name: Korean Endocrine Society – name: 대한내분비학회 |
References | ref13 ref12 ref15 ref14 ref11 ref10 ref17 ref16 ref19 ref18 Abai (ref30) 2021 (ref22) 2002 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 (ref49) 2001 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 (ref28) 2020 ref31 ref33 ref32 ref2 ref39 ref38 Chen (ref1) 2020 ref24 ref23 ref26 ref25 ref20 ref21 ref27 ref29 |
References_xml | – ident: ref44 doi: 10.1152/ajpendo.00301.2007 – ident: ref15 doi: 10.1016/j.exger.2020.110832 – ident: ref42 doi: 10.1515/cclm.2004.072 – ident: ref37 doi: 10.1152/ajpheart.00099.2015 – year: 2021 ident: ref30 – start-page: 89 volume-title: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework year: 2001 ident: ref49 – ident: ref9 doi: 10.1111/ggi.12723 – ident: ref39 doi: 10.1139/cjpp-2020-0093 – ident: ref50 doi: 10.1007/s40520-016-0717-0 – ident: ref2 doi: 10.1016/j.gerinurse.2014.03.001 – ident: ref12 doi: 10.1038/ejcn.2011.151 – year: 2020 ident: ref28 – ident: ref29 doi: 10.1146/annurev.nu.12.070192.001431 – ident: ref5 doi: 10.1016/j.amjcard.2016.01.033 – ident: ref18 doi: 10.1097/bor.0b013e328358d59b – ident: ref4 doi: 10.3945/ajcn.2009.28256 – ident: ref34 doi: 10.1590/s0100-879x2009007500021 – ident: ref36 doi: 10.1038/ejcn.2013.97 – ident: ref41 doi: 10.1016/j.arr.2018.10.010 – ident: ref23 doi: 10.1016/j.ejim.2014.04.011 – ident: ref40 doi: 10.1053/meta.2001.23286 – ident: ref35 doi: 10.1002/jcb.25841 – ident: ref11 doi: 10.1007/s12272-018-1016-4 – ident: ref43 doi: 10.1093/qjmed/hcn112 – start-page: 2015 volume-title: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis year: 2002 ident: ref22 – ident: ref13 doi: 10.1155/2019/9276097 – ident: ref45 doi: 10.3390/ijms140715074 – ident: ref20 doi: 10.1038/s41598-020-76185-0 – ident: ref25 doi: 10.1007/s11864-019-0691-9 – ident: ref17 doi: 10.1007/s12603-013-0336-9 – ident: ref21 doi: 10.1016/s0140-6736(19)31138-9 – ident: ref32 doi: 10.1046/j.1532-5415.2002.50216.x – ident: ref38 doi: 10.1016/j.bbadis.2015.01.008 – ident: ref46 doi: 10.12965/jer.1836268.134 – ident: ref47 doi: 10.1093/ageing/afz046 – ident: ref6 doi: 10.1016/j.jstrokecerebrovasdis.2020.105259 – ident: ref8 doi: 10.1001/jamasurg.2020.2497 – ident: ref16 doi: 10.1093/ajcn/88.3.738 – ident: ref24 doi: 10.1016/j.tipsro.2020.10.001 – ident: ref19 doi: 10.1056/nejm199801013380101 – ident: ref33 doi: 10.1016/j.jamda.2014.11.011 – ident: ref14 doi: 10.1093/gerona/glx161 – start-page: 300 volume-title: Asian Working Group for Sarcopenia: 2019 consensus date on sarcopenia diagnosis and treatment year: 2020 ident: ref1 – ident: ref10 doi: 10.3389/fnut.2019.00049 – ident: ref31 doi: 10.1038/s12276-019-0216-4 – ident: ref3 doi: 10.1016/j.jamda.2014.02.005 – ident: ref27 doi: 10.1136/bmjopen-2017-021232 – ident: ref26 doi: 10.1787/5js1qwkz2p9s-en – ident: ref7 doi: 10.1111/resp.13877 – ident: ref48 doi: 10.1007/s13539-012-0078-2 |
SSID | ssj0000884121 |
Score | 2.2920945 |
Snippet | Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased... Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal... Background Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 333 |
SubjectTerms | Adult Cross-Sectional Studies Homocysteine Humans Hyperhomocysteinemia - epidemiology muscle Muscle, Skeletal Odds Ratio Original sarcopenia skeletal 내과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrggEK_AsjICcSJsHDt-HAvqqiCKkGCl3izHD6i6TVZ9gPbfM5OkVYtAXDglip3IGY893yQz3xDyUsUQuJQ6jzpWOVJ250akOpecC6fAHkeDicLTT3JyKT7MqtlBqS-MCevpgXvBnQunHYAI6ZlKIpTS-AT7rqqDVzxFH3H3LUxx4Ex1e7DWgnVJV9DI88rIWU-wyXXBz8fNFDzDkr1h5fA5ZWeQOt5-MDPNKv0Jcv4eOXlgii7ukjsDhqSjfuz3yK3Y3CfhQNB0iL6i46v4A8BkoJ8BJC8dnbTL1iN3M2BL6ppAP7Y_6ZcFmB7A4HS6XcPz6BTwNJ03dLS-WV5v2o7TlY6Qp2P9gFxejL--m-RDCYXcw8rc5DEKVyipgglFkaT2wnhvWGSsdjV4XiqoCIAkmcpUWuMZr2pvPFYUqiqt-ENy0rRNfExo0qF0sk7wgEIkWRrnNXMhmrL0GlBfRl7v5Gj9wC-OZS6uLPgZKHYLYrcodotiz8irfffrnljjbx3f4qTsOyEfdncBtMQOWmL_pSUZeQFTahd-3t2Px2-tXawseA3vkbe5lErJjDzfTbmFVYa_TlwT2-3alhKJ0gB7VRl51KvAfkCYCyE4LzKijpTjaMTHLc38e8fkbQCQccae_I9XfEpul5ia0UUVnZKTzWobnwFg2tRn3dr4BUm1Etw priority: 102 providerName: Directory of Open Access Journals |
Title | Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35144330 https://www.proquest.com/docview/2628301555 https://pubmed.ncbi.nlm.nih.gov/PMC9081311 https://doaj.org/article/4a8a5086c17f4d269cf4137bdc73fece https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002834865 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Endocrinology and Metabolism, 2022, 37(2), , pp.333-343 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELbQcuGCQLzCY2UE4kSWxE78OCBUUFcFUYQElXqzHNvZrdomS9MC---ZcbNlC4vEKVHiWNbnmcw3if0NIc9l8J4LodKgQpmiZHeqi7pKBeeFlRCPg8aNwuNPYjQpPkzL6W9JoR7A7srUDutJTVaLo5_fzt-Aw7_GjFNl_NWwGUOix_KjnKGs5PX4qwhX8fVMP76UlSryuAuLQQ6fllpMt4qbf_ewF6GikD_EnWZVX8VB_1xKeSk2Hd8iN3tSSQdbK7hNroXmDvGXkKf9ciw6XITvwC49_QyseWnpqF22DsWcgWxS23j6sf1Bv8whFgEedLzpoD86BoJNZw0ddOfLs3UbRV7pAIU7urtkcjz8-m6U9jUVUgeuuk5DKGwmhfTaZ1ktlCu0czoPeV7ZClIx6WUAhlLrUpdK4RkvK6cdlhgqSyX5PXLQtE14QGitPLOiqqGDrKgF09ap3PqgGXMKaGBCXl7gaFwvOI51LxYGEg-E3QDsBmE3CHtCXuyan22VNv7V8C1Oyq4RCmTHC-3qxPT-ZgqrLHBP4XJZF54J7WqwCll5J3kdXEjIM5hSM3ez-DweT1ozXxlII96jkDMTUoqEPL2YcgNuh_9SbBPaTWeYQOU0IGNlQu5vTWA3INwcUXCeJUTuGcfeiPfvNLPTKO2tgaHxPH_4v1g8IjcY7seIS4kek4P1ahOeAEtaV4fx68Jh9IJff9wPWA |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+Elevated+Plasma+Homocysteine+and+Low+Skeletal+Muscle+Mass+in+Asymptomatic+Adults&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Choi%2C+Jae-Hyeong&rft.au=Seo%2C+Jin-Woo&rft.au=Lee%2C+Mi-Yeon&rft.au=Lee%2C+Yong-Taek&rft.date=2022-04-01&rft.issn=2093-596X&rft.eissn=2093-5978&rft.volume=37&rft.issue=2&rft.spage=333&rft.epage=343&rft_id=info:doi/10.3803%2FEnM.2021.1202&rft.externalDBID=n%2Fa&rft.externalDocID=10_3803_EnM_2021_1202 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon |